Thrombophilia or hypercoagulability is a condition in which the blood cell coagulation rate increases, leading to thrombosis. It occurs due to abnormalities in blood such as increase in red blood cells (polycythemia) or increase in platelets (thrombocytosis or thrombocythemia).
This report contains market size and forecasts of Thrombophilia Testing in Global, including the following market information:
Global Thrombophilia Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Thrombophilia Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Automated Testing Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Thrombophilia Testing include Siemens, LabCorp, Instrumentation Laboratory SpA, Johns Hopkins Medicine and Abbott, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Thrombophilia Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Thrombophilia Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Thrombophilia Testing Market Segment Percentages, by Type, 2021 (%)
Automated Testing
Semi-automated Testing
Global Thrombophilia Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Thrombophilia Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Diagnostic Laboratories
Global Thrombophilia Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Thrombophilia Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Thrombophilia Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Thrombophilia Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Siemens
LabCorp
Instrumentation Laboratory SpA
Johns Hopkins Medicine
Abbott